Flu vaccines fast tracked in the EU
The EMEA is racing to fast track the review of data on H1N1 pandemic vaccines before the start of the Northern hemisphere flu season, which is expected to begin in September. More...

BMS to acquire Medarex
In a move to strengthen development of its biologics portfolio, Bristol-Myers Squibb (BMS) has agreed to acquire the biopharmaceutical company Medarex (NJ, USA) for approximately $2.4 billion. More...

Personalized medicine drives M&As
The number of alliances between diagnostics and pharmaceutical companies is set to rise because of the growth of personalized medicine, according to a report from PricewaterhouseCoopers (PwC). More...

New life pumped into UK pharma
The UK's pharma sector will soon receive its own body to help employers drive the key skills agenda of the industry .More...

APIs delivered by sticky webs
GlaxoSmithKline (GSK) has granted 42 Technology worldwide pharmaceutical rights to a new precision powder dispensing technology that can quickly print powdered APIs onto edible or inert webs coated with adhesive to create a novel dose form. More...

Extending antibody shelf life
Researchers working on extending the shelf life of antibody drugs may find help in a computer model developed by a research team at MIT (MA, USA). More...

Sanofi boosts vaccine portfolio
Sanofi aventis's vaccines division, Sanofi Pasteur (France), has acquired the ShanH subsidiary of Mërieux Alliance, which will give Sanofi Pasteur a majority stake in the Indian based vaccine producer Shantha Biotechnics. More...

Transgenic rats provide new models of human disease
Transgenic rats, created using a novel application of zinc finger nuclease (ZFN) technology, could aid the development of animal models of human diseases. More...

Peristaltic pumps are at the centre of many single-use biopharmaceutical processes and medical/surgical instruments. Their non-contacting design makes them uniquely suited to these applications, providing lower contamination risks and reduced validation requirements. Read more...